Difficulty: Medium
Average Score: 71%
Practice
Eradication of H pylori along with gastric antisecretory drugs affords the following benefit(s).
Correct answer
D
Rationale
In the treatment of gastrointestinal disorders, such as peptic ulcers caused by H. pylori infection, combining eradication therapy with gastric antisecretory drugs offers a comprehensive approach to managing the condition. The correct answer, option D, "Both (b) and (c)", highlights the dual benefits of faster ulcer healing (option B) and reduced chance of ulcer relapse (option C) when this combined approach is utilized.
When H. pylori is eradicated along with the use of gastric antisecretory drugs, the synergistic effect leads to faster healing of the ulcer by addressing both the underlying cause (bacterial infection) and reducing the acid secretion that can aggravate the ulcer. This not only provides relief from ulcer pain but also accelerates the healing process, promoting quicker recovery.
Options A and C are incorrect in this context because faster relief of ulcer pain (option A) alone may not address the root cause of the ulcer, while reduced chance of ulcer relapse (option C) is not solely achieved by faster relief of pain but rather by the combined approach of eradicating the bacteria and controlling acid secretion, as highlighted in option D.
Educationally, understanding the rationale behind the benefits of combining H. pylori eradication with gastric antisecretory drugs is crucial for healthcare professionals involved in managing gastrointestinal disorders. This knowledge enables them to provide more effective treatment strategies, improve patient outcomes, and prevent complications associated with peptic ulcers. It underscores the importance of a multifaceted approach in the management of such conditions, emphasizing the need for comprehensive treatment plans tailored to individual patient needs.
When H. pylori is eradicated along with the use of gastric antisecretory drugs, the synergistic effect leads to faster healing of the ulcer by addressing both the underlying cause (bacterial infection) and reducing the acid secretion that can aggravate the ulcer. This not only provides relief from ulcer pain but also accelerates the healing process, promoting quicker recovery.
Options A and C are incorrect in this context because faster relief of ulcer pain (option A) alone may not address the root cause of the ulcer, while reduced chance of ulcer relapse (option C) is not solely achieved by faster relief of pain but rather by the combined approach of eradicating the bacteria and controlling acid secretion, as highlighted in option D.
Educationally, understanding the rationale behind the benefits of combining H. pylori eradication with gastric antisecretory drugs is crucial for healthcare professionals involved in managing gastrointestinal disorders. This knowledge enables them to provide more effective treatment strategies, improve patient outcomes, and prevent complications associated with peptic ulcers. It underscores the importance of a multifaceted approach in the management of such conditions, emphasizing the need for comprehensive treatment plans tailored to individual patient needs.